SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
RHYTHM PHARMACEUTICALS, INC.
@RYTM_InsiderForm 4 Filing: JEAN CHRISTOPHE Exercises Options for shares of $RYTM
OPTION EXERCISE
⚡ MATERIALITY: 2/10
corporate issuer
RHYTHM PHARMACEUTICALS, INC.
Ticker: $RYTM
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-23
Shares: 4,712
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, JEAN CHRISTOPHE, holds the title of Director at RHYTHM PHARMACEUTICALS, INC..
On 2026-06-23, the insider transacted 4,712 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
JEAN CHRISTOPHE (Director) exercised options for $0 of $RYTM
Post-Transaction Position: 11,712 shares
SEC Accession No: 0001104659-26-077867 (CIK: 1378435)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.